These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens. Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group. J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304 [Abstract] [Full Text] [Related]
7. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa. Marais D, Rose RC, Williamson AL. J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543 [Abstract] [Full Text] [Related]
10. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ. J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700 [Abstract] [Full Text] [Related]
11. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730 [Abstract] [Full Text] [Related]
14. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection. Wikström A, van Doornum GJ, Kirnbauer R, Quint WG, Dillner J. J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415 [Abstract] [Full Text] [Related]
17. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan. Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A, Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y, Kanda T. J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056 [Abstract] [Full Text] [Related]
19. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. Rose RC, Reichman RC, Bonnez W. J Gen Virol; 1994 Aug; 75 ( Pt 8)():2075-9. PubMed ID: 8046412 [Abstract] [Full Text] [Related]